Dillon & Associates Inc Stryker Corp Transaction History

Dillon & Associates Inc

  • $711 Million
  • Q3 2024

A detailed history of Dillon & Associates Inc transactions in Stryker Corp stock. As of the latest transaction made, Dillon & Associates Inc holds 86,293 shares of SYK stock, worth $31.9 Million. This represents 4.38% of its overall portfolio holdings.

Number of Shares
86,293
Previous 84,474 2.15%
Holding current value
$31.9 Million
Previous $28.7 Million 8.46%
% of portfolio
4.38%
Previous 4.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$315.94 - $371.96 $574,694 - $676,595
1,819 Added 2.15%
86,293 $31.2 Million
Q2 2024

Aug 06, 2024
BUY
$324.3 - $354.67 $475,099 - $519,591
1,465 Added 1.76%
84,474 $28.7 Million
Q1 2024

Apr 30, 2024
SELL
$293.94 - $358.71 $236,327 - $288,402
-804 Reduced 0.96%
83,009 $29.7 Million
Q4 2023

Feb 08, 2024
SELL
$253.85 - $299.46 $685,902 - $809,140
-2,702 Reduced 3.12%
83,813 $25.1 Million
Q3 2023

Nov 13, 2023
SELL
$266.54 - $302.43 $64,502 - $73,188
-242 Reduced 0.28%
86,515 $23.6 Million
Q2 2023

Aug 08, 2023
SELL
$271.49 - $305.09 $940,712 - $1.06 Million
-3,465 Reduced 3.84%
86,757 $26.5 Million
Q1 2023

May 02, 2023
SELL
$246.13 - $285.47 $673,165 - $780,760
-2,735 Reduced 2.94%
90,222 $25.7 Million
Q1 2023

May 01, 2023
BUY
$246.13 - $285.47 $120,357 - $139,594
489 Added 0.53%
92,957 $26.5 Million
Q4 2022

Feb 06, 2023
SELL
$205.51 - $253.93 $125,155 - $154,643
-609 Reduced 0.65%
92,468 $22.6 Million
Q3 2022

Nov 08, 2022
BUY
$189.27 - $231.83 $227,313 - $278,427
1,201 Added 1.31%
93,077 $18.9 Million
Q2 2022

Jul 26, 2022
SELL
$194.09 - $276.37 $48,522 - $69,092
-250 Reduced 0.27%
91,876 $18.3 Million
Q1 2022

May 06, 2022
SELL
$245.33 - $277.77 $203,869 - $230,826
-831 Reduced 0.89%
92,126 $24.6 Million
Q4 2021

Feb 14, 2022
BUY
$236.63 - $276.44 $86,843 - $101,453
367 Added 0.4%
92,957 $24.8 Million
Q3 2021

Oct 28, 2021
SELL
$248.9 - $280.09 $317,347 - $357,114
-1,275 Reduced 1.36%
92,590 $24.4 Million
Q2 2021

Aug 02, 2021
SELL
$242.95 - $267.0 $448,728 - $493,149
-1,847 Reduced 1.93%
93,865 $24.4 Million
Q1 2021

May 10, 2021
SELL
$221.01 - $248.82 $436,494 - $491,419
-1,975 Reduced 2.02%
95,712 $23.4 Million
Q4 2020

Feb 12, 2021
SELL
$202.01 - $245.04 $243,826 - $295,763
-1,207 Reduced 1.22%
97,687 $23.9 Million
Q3 2020

Nov 06, 2020
SELL
$177.77 - $215.81 $45,686 - $55,463
-257 Reduced 0.26%
98,894 $20.6 Million
Q2 2020

Jul 28, 2020
SELL
$144.67 - $207.03 $20,398 - $29,191
-141 Reduced 0.14%
99,151 $17.8 Million
Q1 2020

May 07, 2020
BUY
$126.5 - $225.1 $496,386 - $883,292
3,924 Added 4.11%
99,292 $16.5 Million
Q4 2019

Feb 03, 2020
SELL
$197.98 - $220.53 $43,951 - $48,957
-222 Reduced 0.23%
95,368 $20 Million
Q3 2019

Oct 25, 2019
BUY
$205.4 - $221.82 $41,080 - $44,364
200 Added 0.21%
95,590 $20.6 Million
Q2 2019

Jul 22, 2019
BUY
$180.24 - $205.58 $371,835 - $424,111
2,063 Added 2.21%
95,390 $19.7 Million
Q1 2019

May 07, 2019
SELL
$152.46 - $198.0 $23,631 - $30,690
-155 Reduced 0.17%
93,327 $18.5 Million
Q4 2018

Feb 14, 2019
SELL
$145.0 - $178.65 $182,845 - $225,277
-1,261 Reduced 1.33%
93,482 $14.7 Million
Q3 2018

Nov 14, 2018
SELL
$163.25 - $177.68 $85,379 - $92,926
-523 Reduced 0.55%
94,743 $16.9 Million
Q2 2018

Aug 08, 2018
SELL
$155.17 - $179.78 $77,740 - $90,069
-501 Reduced 0.52%
95,266 $16.1 Million
Q1 2018

May 08, 2018
SELL
$148.01 - $168.91 $159,258 - $181,747
-1,076 Reduced 1.11%
95,767 $15.4 Million
Q4 2017

Feb 08, 2018
SELL
$143.51 - $159.74 $360,066 - $400,787
-2,509 Reduced 2.53%
96,843 $15 Million
Q3 2017

Nov 13, 2017
SELL
$138.36 - $147.87 $1,383 - $1,478
-10 Reduced 0.01%
99,352 $14.1 Million
Q2 2017

Aug 09, 2017
BUY
N/A
99,362
99,362 $13.8 Million

Others Institutions Holding SYK

# of Institutions
2,231
Shares Held
284M
Call Options Held
1.35M
Put Options Held
1.6M
View Full List

About STRYKER CORP

SYK Quotes by TradingView
  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $140B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email